ACE and diabetes mellitus: Given the small sample size of exclusively diabetic patients, the high event rate among the medically managed group and advances that have occurred in the medical management of diabetes and ischemic heart disease, including the use of angiotensin-converting enzyme inhibitors and statins, the findings of this study are no longer applicable to contemporary practice.